Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Enroute 0.014'' Transcarotid Guidewire

K-Number: K253746 · 2026-03-19

Decision Date2026-03-19
Product CodeDQX
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

Enroute 0.014'' Transcarotid Guidewire is a medical device manufactured by Lake Region Medical. It received FDA 510(k) clearance on 2026-03-19 under approval number K253746. The device is classified under product code DQX. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Enroute 0.014'' Transcarotid Guidewire?

Enroute 0.014'' Transcarotid Guidewire is a medical device that received FDA 510(k) clearance on 2026-03-19. It is manufactured by Lake Region Medical. The 510(k) number is K253746.

When was Enroute 0.014'' Transcarotid Guidewire approved by the FDA?

Enroute 0.014'' Transcarotid Guidewire received FDA 510(k) clearance on 2026-03-19, under approval number K253746.

What company makes Enroute 0.014'' Transcarotid Guidewire?

Enroute 0.014'' Transcarotid Guidewire is manufactured by Lake Region Medical.

What is the FDA product code for Enroute 0.014'' Transcarotid Guidewire?

The FDA product code for Enroute 0.014'' Transcarotid Guidewire is DQX.

Related Clinical Trials

Other Devices by Lake Region Medical

Related Devices (Code: DQX)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.